Enliven Therapeutics, Inc. of BOULDER, CO, a company, filed a Form D exempt-offering notice with the SEC on 2019-03-29. The offering totals $63.0M, of which $44.1M was reported sold. Industry: Pharmaceuticals.
Showing 25 of 30 people.
| Name | Role | Location |
|---|---|---|
| Mette Kirstine Agger | Director | CAMBRIDGE, MA |
| Rahul Ballal | Director | Boston, MA |
| David G Bonita | Director | CAMBRIDGE, MA |
| Mark G Chin | Director | CAMBRIDGE, MA |
| Barbara G Dalton | Director | CAMBRIDGE, MA |
| Carl G Goldfischer | Director | CAMBRIDGE, MA |
| James G McArthur | Director | CAMBRIDGE, MA |
| David G Mott | Director | CAMBRIDGE, MA |
| Sara G Nayeem | Director | CAMBRIDGE, MA |
| Christoph M Adams | Executive Officer | CAMBRIDGE, MA |
| Rahul Ballal | Executive Officer | Boston, MA |
| Helen P Collins | Executive Officer | Boulder, CO |
| Andrew P Phillips | Director | Boulder, CO |
| Richard P Heyman | Director | Boulder, CO |
| Mika P Derynck | Director | Boulder, CO |
| Benjamin P Hohl | Executive Officer | Boulder, CO |
| Anish P Patel | Executive Officer | Boulder, CO |
| Joseph P Lyssikatos | Director | Boulder, CO |
| Joseph P Lyssikatos | Executive Officer | Boulder, CO |
| Jake P Bauer | Director | Boulder, CO |
| Rahul P Ballal | Director | Boulder, CO |
| Rishi P Gupta | Director | Boulder, CO |
| Samuel Kintz | Director | Boulder, CO |
| Samuel Kintz | Executive Officer | Boulder, CO |
| Christoph M Adams | Director | CAMBRIDGE, MA |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2024-04-03 | D | $90.0M | $90.0M |
| 2016-04-21 | D | $31.0M | $6.0M |